for the Period Ended 31 December 2025
| Balance sheet | |
| Additional notes | |
| Community Interest Report |
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Members' funds | |||
| Profit and loss account: |
|
|
|
| Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 December 2025
Basis of measurement and preparation
for the Period Ended 31 December 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
1247 Trisomy CIC remained dormant during the financial year and did not undertake any trading activities. The company was established to raise awareness and provide support around Trisomy 21 (Down syndrome). During this period, we focused on developing our future plans and preparing the organisation to support individuals and families within the community. No income was received and no expenditure was incurred during the financial year.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
21 September 2026
And signed on behalf of the board by:
Name: Jordan Dunkley-Dixon
Status: Director